<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32671691</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2240-2993</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Acta neurologica Belgica</Title><ISOAbbreviation>Acta Neurol Belg</ISOAbbreviation></Journal><ArticleTitle>Phenotypic and genotypic features of patients diagnosed with ALS in the city of Sakarya, Turkey.</ArticleTitle><Pagination><StartPage>1411</StartPage><EndPage>1418</EndPage><MedlinePgn>1411-1418</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13760-020-01441-z</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease leading to motor neuron damage. In this study, the clinical, demographic, and genetic features of ALS patients in the city of Sakarya, Turkey, were investigated. Patients with an established diagnosis of ALS according to the Awaji criteria were included. Age, sex, age at onset of ALS, initial complaints, consanguineous marriage, and genetic features were retrospectively investigated. Conventional genetic analysis and NGS were used for molecular evaluation of patients. A total of 55 probands (10 familial, 45 sporadic) in whom ALS was suspected due to their phenotypic features were included. Thirty-two patients were male (58.2%), and 23 were female (41.8%); their mean ages were 62.65&#x2009;&#xb1;&#x2009;13&#xa0;years. The mean age of onset for 37 familial patients from 10 families was 49.9&#xa0;years. Two cases had juvenile-onset. Fourteen (25.5%) bulbar-onset versus 40 (72.7%) limb-onset patients were detected; one patient had both. Six (10.9%) patients showed marked frontotemporal dementia. Twenty-nine (52.7%) patients died during the follow-up period. Genetic analysis identified causative variants in eleven cases, carrying variants in six different ALS genes (C9orf72, SOD1, VCP, SPG11, TBK1, and SH3TC2). Genetic investigations have revealed more than 40 genes to be involved in the pathogenesis of ALS. Our relatively small study cohort restricted to one province of Turkey, however, prone to migration, consists of 10/55 familial ALS cases, which harbor two rare (SH3TC2-p.Met523Thr and TBK1-p.Glu643del) and two novel (SPG11-p.Lys656Valfs*11 and VCP-p.Arg191Pro) mutations contributing to the literature.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kotan</LastName><ForeName>Dilcan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Sakarya University Faculty of Medicine, Sakarya, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;z&#xf6;zen Ayas</LastName><ForeName>Zeynep</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-9302-5543</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Eski&#x15f;ehir City Hospital, Eski&#x15f;ehir, Turkey. zozozen@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tunca</LastName><ForeName>Ceren</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), KUTTAM, Ko&#xe7; University School of Medicine, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gungen</LastName><ForeName>Belma Dogan</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Department of Neurology, &#x130;stinye University Hospital, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ak&#xe7;imen</LastName><ForeName>Fulya</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Genetics, Neurodegeneration Research Laboratory (NDAL), Bo&#x11f;azi&#xe7;i University, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ba&#x15f;ak</LastName><ForeName>A Nazl&#x131;</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Suna and &#x130;nan K&#x131;ra&#xe7; Foundation, Neurodegeneration Research Laboratory (NDAL), KUTTAM, Ko&#xe7; University School of Medicine, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Acta Neurol Belg</MedlineTA><NlmUniqueID>0247035</NlmUniqueID><ISSNLinking>0300-9009</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C520412">SPG11 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.-</RegistryNumber><NameOfSubstance UI="D008780">Methyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.-</RegistryNumber><NameOfSubstance UI="C577899">VCPKMT protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008780" MajorTopicYN="N">Methyltransferases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014421" MajorTopicYN="N" Type="Geographic">Turkey</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Familial</Keyword><Keyword MajorTopicYN="N">Genetic analysis</Keyword><Keyword MajorTopicYN="N">Sakarya district</Keyword><Keyword MajorTopicYN="N">Sporadic</Keyword><Keyword MajorTopicYN="N">Turkey</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32671691</ArticleId><ArticleId IdType="doi">10.1007/s13760-020-01441-z</ArticleId><ArticleId IdType="pii">10.1007/s13760-020-01441-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Deenen J, Horlings C, Verschuuren J, Verbeek ALM, van Engelen BGM (2015) The epidemiology of neuromuscular disorders: a comprehensive overview of the literature. J Neuromuscul Dis 2:73&#x2013;85</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-140045</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Regod&#xf3;n Wallin A, Samuelsson K, Press R, Zachau A, Ronnevi LO et al (2018) The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degener 19(7&#x2013;8):528&#x2013;537. https://doi.org/10.1080/21678421.2018.1497065</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1497065</ArticleId></ArticleIdList></Reference><Reference><Citation>Leighton DJ, Newton J, Stephenson LJ, Colville S, Davenport R, Gorrie G et al (2019) Changing epidemiology of motor neurone disease in Scotland. J Neurol 266(4):817&#x2013;825. https://doi.org/10.1007/s00415-019-09190-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09190-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Kaye W, Raymond J, Punjani R, Larson T, Cohen J et al (2018) Prevalence of amyotrophic lateral sclerosis: United States. MMWR Morb Mortal Wkly Rep 67(46):1285&#x2013;1289. https://doi.org/10.15585/mmwr.mm6746a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6746a1</ArticleId></ArticleIdList></Reference><Reference><Citation>Turgut N, Sara&#xe7;o&#x11f;lu GV, Kat S, Balci K, G&#xfc;ldiken B, Birgili O et al (2019) An epidemiologic investigation of amyotrophic lateral sclerosis in Thrace, Turkey, 2006&#x2013;2010. Amyotroph Lateral Scler Frontotemporal Degener 20(1&#x2013;2):100&#x2013;106. https://doi.org/10.1080/21678421.2018.1525403</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1525403</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor B, Collins J, Simeone JC, Goldstein LA et al (2013) Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41(2):118&#x2013;140. https://doi.org/10.1159/000351153</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M, Heverin M, McLaughlin RL, Hardiman O (2019) Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol 76(11):1367&#x2013;1374. https://doi.org/10.1001/jamaneurol.2019.2044</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2044</ArticleId></ArticleIdList></Reference><Reference><Citation>Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Clarke J et al (2007) Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology 29(1&#x2013;2):44&#x2013;48. https://doi.org/10.1159/000108917</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000108917</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C, Mazzini L, Mora G, PARALS study group (2011) Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 82(7):740&#x2013;746. https://doi.org/10.1136/jnnp.2010.235952</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377(2):162&#x2013;172. https://doi.org/10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O (1999) Incidence and prevalence of ALS in Ireland, 1995&#x2013;1997: a population-based study. Neurology 52(3):504&#x2013;509. https://doi.org/10.1212/wnl.52.3.504</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.52.3.504</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G, SLALOM Group (2007) Incidence of ALS in Lombardy, Italy. Neurology 68(2):141&#x2013;145. https://doi.org/10.1212/01.wnl.0000250339.14392.bb</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000250339.14392.bb</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;zquez MC, Ketzoi&#xe1;n C, Legnani C, Rega I, S&#xe1;nchez N, Perna A et al (2008) Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study. Neuroepidemiology 30(2):105&#x2013;111. https://doi.org/10.1159/000120023</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000120023</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman MH, de Jong SW, van Doormaal PT, Weinreich SS, Schelhaas HJ, van der Kooi AJ et al (2011) Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry 82(10):1165&#x2013;1170. https://doi.org/10.1136/jnnp.2011.244939</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2011.244939</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F, Valdimarsdottir U, Bellocco R, Ronnevi LO, Spar&#xe9;n L, Fall K et al (2009) Amyotrophic lateral sclerosis in Sweden, 1991&#x2013;2005. Arch Neurol 66(4):515&#x2013;519. https://doi.org/10.1001/archneurol.2009.13</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2009.13</ArticleId></ArticleIdList></Reference><Reference><Citation>Uenal H, Rosenbohm A, Kufeldt J, Weydt P, Goder K, Ludolph A et al (2014) Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany completeness of the ALS registry Swabia. PLoS ONE 9(4):e93932. https://doi.org/10.1371/journal.pope.0093932</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pope.0093932</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto K, Hirai S, Yamazaki T, Sun X, Nakazato Y (1991) New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosc Lett 129:233&#x2013;236. https://doi.org/10.1016/0304-3940(91)90469-a</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(91)90469-a</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B et al (2008) Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 79:30&#x2013;32. https://doi.org/10.1136/jnnp.2007.117788</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2007.117788</ArticleId></ArticleIdList></Reference><Reference><Citation>Handy CR, Krudy C, Boulis N, Federici T (2011) Pain in amyotrophic lateral sclerosis: a neglected aspect of disease. Neurol Res Int 2011:403808. https://doi.org/10.1155/2011/403808</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/403808</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J et al (2008) Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 119(3):497&#x2013;503. https://doi.org/10.1016/j.clinph.2007.09.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M, Brown RH Jr (2018) Genetics of amyotrophic lateral sclerosis. Cold Spring Harbour Perspect Med 27:a024125&#x2013;a024125. https://doi.org/10.1101/cshperspect.a024125</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024125</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S, Siddique T (1852) 2015) Sporadic and hereditary amyotrophic lateral sclerosis (ALS. Biochim Biophys Acta 4:679&#x2013;684. https://doi.org/10.1016/j.bbais.2014.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbais.2014.08.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder DW, Kurland LT, Offord KP, Beard CM (1986) Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36:511&#x2013;517. https://doi.org/10.1212/wnl.36.4.511</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.36.4.511</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf3; A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17(1):17&#x2013;23. https://doi.org/10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323(5918):1208&#x2013;1211. https://doi.org/10.1126/science.1165942</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942&#x2013;955. https://doi.org/10.1016/S0140-6736(10)61156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11:323&#x2013;330. https://doi.org/10.1016/S1474-4422(12)70043-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, van den Berg LH, Kiernan MC (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 7:639&#x2013;649. https://doi.org/10.1038/nrneurol.2011.153</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.153</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogel BL, Satya-Murti S, Cohen BH (2016) Clinical exome sequencing in neurologic disease. Neurol Clin Pract 6(2):164&#x2013;176. https://doi.org/10.1212/CPJ.0000000000000239</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000000239</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH (2011) Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management. CNS Drugs 25(1):1&#x2013;15. https://doi.org/10.2165/11586000-000000000-00000</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11586000-000000000-00000</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S, Carr K, Reiley L, Diaz K, Orleiquis G, Altamirano PF et al (2015) A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int 6:171. https://doi.org/10.4103/2152-7806.169561</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin S, Hardiman O, Traynor BJ (2007) Ethnic variation in the incidence of ALS: a systematic review. Neurology 68(13):1002&#x2013;1007. https://doi.org/10.1212/01.wnl.0000258551.96893.6f</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000258551.96893.6f</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, Chi&#xf3; A, Mitchell D, Swinger RJ et al (2010) Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 81(4):385&#x2013;390. https://doi.org/10.1136/jnnp.2009.183525</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf3; A, Moglia C, Canosa A, Umberto M, Dovidio F, Vasta R et al (2020) ALS phenotype is inflenced by age, sex, and genetics. A population-based study. Neurology 94(8):e802&#x2013;e810. https://doi.org/10.1212/WNL.0000000000008869</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008869</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zoguz A, Uyan &#xd6;, Birdal G, Iskender C, Kartal E, Lahut S et al (2015) The distinct genetic pattern of ALS in Turkey and novel mutations. Neurobiol Aging 36:1764.e9&#x2013;1764. https://doi.org/10.1016/j.neurobiolaging.2014.12.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.12.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralli M, Lambiase A, Artico M, de Vincentiis MGA (2019) Amyotrophic lateral sclerosis: autoimmune pathogenic mechanism, clinical features, and therapeutic perspectives. Isr Med Assoc J 21(7):438&#x2013;443</Citation></Reference><Reference><Citation>Turner MR, Barnwell J, Al-Chalabi A, Eisen A (2012) Young-onset amyotrophic lateral sclerosis: historical and other observations. Brain 35:2883&#x2013;2891. https://doi.org/10.1016/j.ncl.2015.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawdat O, Statland JM, Barohn RJ, Katz JS, Dimachkie MM (2015) Amyotrophic lateral sclerosis regional variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis). Neurol Clin 34:775&#x2013;785</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.003</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, Corrado L, Bersano E, Sarnelli MF, Solara V, D&#x2019;Alfonso S et al (2018) Ptosis and bulbar onset: an unusual phenotype of familial ALS? Neurol Sci 39(2):377&#x2013;378. https://doi.org/10.1007/s017-3186-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s017-3186-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S, Corcia P, Cazeneuve C, Boillee S, Seilhean D, Danel-Brunaud V et al (2012) Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis. Neurobiol Aging 33(839):e1&#x2013;3. https://doi.org/10.1016/j.neurobiolaging.2011.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.11.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Khani M, Alavi A, Nafissi S, Elahi E (2015) Observation of c.260A &gt; G mutation in superoxide dismutase 1 that causes p.Asn86Ser in Iranian amyotrophic lateral sclerosis patient and absence of genotype/phenotype correlation. Iran J Neurol 14(3):152&#x2013;157</Citation></Reference><Reference><Citation>Bouslam N, Bouhouche A, Benomar A, Hanein S, Klebe S, Azzedine H et al (2007) A novel locus for autosomal recessive spastic ataxia on chromosome 17p. Hum Genet 121(3&#x2013;4):413&#x2013;420. https://doi.org/10.1007/s00439-007-0328-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-007-0328-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H, Zhou S, Noreau A, Sabbagh M, Belzil V, Dionne-Laporte A et al (2012) Exome sequencing reveals SPG11 mutations causing juvenile ALS. Neurobiol Aging 33(4):839. https://doi.org/10.1016/j.neurobiolaging.2011.11.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.11.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS et al (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347(6229):1436&#x2013;1441. https://doi.org/10.1126/science.aaa3650</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I, De Septenville A, Millecamps S, Camuzat A, Caroppo P, Couratier P et al (2015) TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts. Neurobiol Aging 36(11):3116.e3115&#x2013;3118. https://doi.org/10.1016/j.neurobiolaging.2015.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.08.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I, Van Mossevelde S, van der Zee J, Sieben A, Philtjens S, Heeman B et al (2015) Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology 85(24):2116&#x2013;2125. https://doi.org/10.1212/WNL.0000000000002220</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002220</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C, Bieniek KF, Finch N, van de Vorst M, Baker M, Perkersen R et al (2015) Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol 130(1):77&#x2013;92. https://doi.org/10.1007/s00401-015-1436-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1436-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnaud E, Zenker J, de Preux Charles AS, Stendel C, Roos A, M&#xe9;dard JJ et al (2009) SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system. Proc Natl Acad Sci USA 106:17528&#x2013;17533. https://doi.org/10.1073/pnas.0905523106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0905523106</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Delumeau JC, Bejuit R, Truffinet P, Meininger V et al (2002) A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis. J Neurol 249:609&#x2013;615. https://doi.org/10.1007/s004150200071</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004150200071</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>